This inventor holds 1 USPTO granted patent. Top assignee: Innate Pharma, S.a.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Ibrahim Zgani: Innovator in Phosphonate Derivatives
Introduction
Ibrahim Zgani is a notable inventor based in Richmond, VA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on phosphonate derivatives.
Latest Patents
Ibrahim Zgani holds a patent for "Phosphonates useful as modulators of T-γ9δ2 activity." This invention concerns novel phosphonate derivatives, their preparation methods, and their use as ligands that modulate T γ9δ2 lymphocyte activity. The patent also includes pharmaceutical compositions that comprise these phosphonates. He has 1 patent to his name.
Career Highlights
Zgani is currently associated with Innate Pharma, S.A., a company that focuses on developing innovative immunotherapies for cancer treatment. His work at Innate Pharma has allowed him to explore the therapeutic potential of his inventions in a practical setting.
Collaborations
Ibrahim has collaborated with notable colleagues such as Jean-Louis Montero and Chantal Menut. Their combined expertise has contributed to advancements in their respective fields.
Conclusion
Ibrahim Zgani is a distinguished inventor whose work on phosphonate derivatives has the potential to impact the pharmaceutical industry significantly. His contributions reflect a commitment to innovation and collaboration in the pursuit of medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile